ReP USP - Resultado da busca

Artigo de periodico
Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial (2020)
Furtado, Remo H. M; Venkateswaran, Ramkumar V; Nicolau, José Carlos ; Gurmu, Yared; Bhatt, Deepak L; Storey, Robert F; Steg, P. Gabriel; Magnani, Giuglia; Goto, Shinya; Dellborg, Mikael
Source: Journal of the american heart association. Unidade: FM
Subjects: CAFEÍNA, DISPNEIA, MORTALIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FURTADO, Remo H. M et al. Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial. Journal of the american heart association, v. 9, n. 10, 2020Tradução . . Disponível em: https://doi.org/10.1161/JAHA.119.015785. Acesso em: 03 nov. 2024.
APA
Furtado, R. H. M., Venkateswaran, R. V., Nicolau, J. C., Gurmu, Y., Bhatt, D. L., Storey, R. F., et al. (2020). Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial. Journal of the american heart association, 9( 10). doi:10.1161/JAHA.119.015785
NLM
Furtado RHM, Venkateswaran RV, Nicolau JC, Gurmu Y, Bhatt DL, Storey RF, Steg PG, Magnani G, Goto S, Dellborg M. Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial [Internet]. Journal of the american heart association. 2020 ; 9( 10):[citado 2024 nov. 03 ] Available from: https://doi.org/10.1161/JAHA.119.015785
Vancouver
Furtado RHM, Venkateswaran RV, Nicolau JC, Gurmu Y, Bhatt DL, Storey RF, Steg PG, Magnani G, Goto S, Dellborg M. Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial [Internet]. Journal of the american heart association. 2020 ; 9( 10):[citado 2024 nov. 03 ] Available from: https://doi.org/10.1161/JAHA.119.015785
Artigo de periodico
Ticagrelor in patients with stable coronary disease and diabetes (2019)
Steg, P. Gabriel; Bhatt, Deepak L; Simon, Tabassome; Fox, Kim; Mehta, Shamir R; Harrington, Robert A; Held, Claes; Andersson, Marielle; Himmelmann, Anders; Nicolau, José Carlos
Source: New england journal of medicine. Unidade: FM
Subjects: CORONARIOPATIA, DIABETES MELLITUS, ADENOSINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STEG, P. Gabriel et al. Ticagrelor in patients with stable coronary disease and diabetes. New england journal of medicine, v. 381, n. 14, p. 1309-1320, 2019Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa1908077. Acesso em: 03 nov. 2024.
APA
Steg, P. G., Bhatt, D. L., Simon, T., Fox, K., Mehta, S. R., Harrington, R. A., et al. (2019). Ticagrelor in patients with stable coronary disease and diabetes. New england journal of medicine, 381( 14), 1309-1320. doi:10.1056/NEJMoa1908077
NLM
Steg PG, Bhatt DL, Simon T, Fox K, Mehta SR, Harrington RA, Held C, Andersson M, Himmelmann A, Nicolau JC. Ticagrelor in patients with stable coronary disease and diabetes [Internet]. New england journal of medicine. 2019 ; 381( 14): 1309-1320.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1056/NEJMoa1908077
Vancouver
Steg PG, Bhatt DL, Simon T, Fox K, Mehta SR, Harrington RA, Held C, Andersson M, Himmelmann A, Nicolau JC. Ticagrelor in patients with stable coronary disease and diabetes [Internet]. New england journal of medicine. 2019 ; 381( 14): 1309-1320.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1056/NEJMoa1908077
Artigo de periodico
Reduction in aubtypes and sizes of myocardial infarction with ticagrelor in PEGASUS-TIMI 54 (2018)
Bonaca, Marc P.; Wiviott, Stephen D; Morrow, David A; Steg, P. Gabriel; Hamm, Christian; Bhatt, Deepak L; Storey, Robert F; Cohen, Marc; Kuder, Julia; Nicolau, José Carlos
Source: Journal of the american heart association. Unidade: FM
Subjects: INFARTO DO MIOCÁRDIO, AGREGAÇÃO PLAQUETÁRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONACA, Marc P. et al. Reduction in aubtypes and sizes of myocardial infarction with ticagrelor in PEGASUS-TIMI 54. Journal of the american heart association, v. 7, n. 22, 2018Tradução . . Disponível em: https://doi.org/10.1161/JAHA.118.009260. Acesso em: 03 nov. 2024.
APA
Bonaca, M. P., Wiviott, S. D., Morrow, D. A., Steg, P. G., Hamm, C., Bhatt, D. L., et al. (2018). Reduction in aubtypes and sizes of myocardial infarction with ticagrelor in PEGASUS-TIMI 54. Journal of the american heart association, 7( 22). doi:10.1161/JAHA.118.009260
NLM
Bonaca MP, Wiviott SD, Morrow DA, Steg PG, Hamm C, Bhatt DL, Storey RF, Cohen M, Kuder J, Nicolau JC. Reduction in aubtypes and sizes of myocardial infarction with ticagrelor in PEGASUS-TIMI 54 [Internet]. Journal of the american heart association. 2018 ; 7( 22):[citado 2024 nov. 03 ] Available from: https://doi.org/10.1161/JAHA.118.009260
Vancouver
Bonaca MP, Wiviott SD, Morrow DA, Steg PG, Hamm C, Bhatt DL, Storey RF, Cohen M, Kuder J, Nicolau JC. Reduction in aubtypes and sizes of myocardial infarction with ticagrelor in PEGASUS-TIMI 54 [Internet]. Journal of the american heart association. 2018 ; 7( 22):[citado 2024 nov. 03 ] Available from: https://doi.org/10.1161/JAHA.118.009260
Artigo de periodico
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial (2017)
Ohman, E. Magnus; Roe, Matthew T.; Steg, P. Gabriel; James, Stefan K.; Povsic, Thomas J.; White, Jennifer; Rockhold, Frank; Plotnikov, Alexei; Mundl, Hardi; Strony, John; Sun, Xiang; Husted, Steen; Tendera, Michal; Montalescot, Gilles; Bahit, M. Cecilia; Ardissino, Diego; Bueno, Héctor; Claeys, Marc J.; Nicolau, Jose C.; Cornel, Jan H.; Goto, Shinya; Kiss, Róbert Gábor; Güray, Ümit; Park, Duk-Woo; Bode, Christoph; Welsh, Robert C.; Gibson, C. Michael
Source: Lancet. Unidade: FM
Subjects: FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, ANTICOAGULANTES, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OHMAN, E. Magnus et al. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. Lancet, v. 389, n. 10081, p. 1799-1808, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(17)30751-1. Acesso em: 03 nov. 2024.
APA
Ohman, E. M., Roe, M. T., Steg, P. G., James, S. K., Povsic, T. J., White, J., et al. (2017). Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. Lancet, 389( 10081), 1799-1808. doi:10.1016/S0140-6736(17)30751-1
NLM
Ohman EM, Roe MT, Steg PG, James SK, Povsic TJ, White J, Rockhold F, Plotnikov A, Mundl H, Strony J, Sun X, Husted S, Tendera M, Montalescot G, Bahit MC, Ardissino D, Bueno H, Claeys MJ, Nicolau JC, Cornel JH, Goto S, Kiss RG, Güray Ü, Park D-W, Bode C, Welsh RC, Gibson CM. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial [Internet]. Lancet. 2017 ; 389( 10081): 1799-1808.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/S0140-6736(17)30751-1
Vancouver
Ohman EM, Roe MT, Steg PG, James SK, Povsic TJ, White J, Rockhold F, Plotnikov A, Mundl H, Strony J, Sun X, Husted S, Tendera M, Montalescot G, Bahit MC, Ardissino D, Bueno H, Claeys MJ, Nicolau JC, Cornel JH, Goto S, Kiss RG, Güray Ü, Park D-W, Bode C, Welsh RC, Gibson CM. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial [Internet]. Lancet. 2017 ; 389( 10081): 1799-1808.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/S0140-6736(17)30751-1
Trabalho de evento-resumo periodico
P2Y12 inhibitor switching in response to routine notification of CYP2C19 clopidogrel metabolizer status following acute coronary syndromes (2017)
Roe, Matthew T; Ohman, E. Magnus; Povsic, Thomas J; White, Jennifer; Rockold, Frank; Montalescot, Gilles; Cornel, Jan H; Nicolau, José Carlos; Steg, P. Gabriel; Gibson, C. Michael
Source: Circulation. Conference titles: 2017 AHA Late-Breaking Sciences Abstracts. Unidade: FM
Subjects: SÍNDROME CORONARIANA AGUDA, PLAQUETAS SANGUÍNEAS, CONDUTAS TERAPÊUTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROE, Matthew T et al. P2Y12 inhibitor switching in response to routine notification of CYP2C19 clopidogrel metabolizer status following acute coronary syndromes. Circulation. Dallas: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1161/CIR.0000000000000546. Acesso em: 03 nov. 2024. , 2017
APA
Roe, M. T., Ohman, E. M., Povsic, T. J., White, J., Rockold, F., Montalescot, G., et al. (2017). P2Y12 inhibitor switching in response to routine notification of CYP2C19 clopidogrel metabolizer status following acute coronary syndromes. Circulation. Dallas: Faculdade de Medicina, Universidade de São Paulo. doi:10.1161/CIR.0000000000000546
NLM
Roe MT, Ohman EM, Povsic TJ, White J, Rockold F, Montalescot G, Cornel JH, Nicolau JC, Steg PG, Gibson CM. P2Y12 inhibitor switching in response to routine notification of CYP2C19 clopidogrel metabolizer status following acute coronary syndromes [Internet]. Circulation. 2017 ; 136( 24): e458-e459.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1161/CIR.0000000000000546
Vancouver
Roe MT, Ohman EM, Povsic TJ, White J, Rockold F, Montalescot G, Cornel JH, Nicolau JC, Steg PG, Gibson CM. P2Y12 inhibitor switching in response to routine notification of CYP2C19 clopidogrel metabolizer status following acute coronary syndromes [Internet]. Circulation. 2017 ; 136( 24): e458-e459.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1161/CIR.0000000000000546
Artigo de periodico
Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease (2014)
White, Harvey D.; Held, Claes; Stewart, Ralph; Tarka, Elizabeth; Brown, Rebekkah; Davies, Richard Y.; Budaj, Andrzej; Harrington, Robert A.; Steg, P. Gabriel; Ardissino, Diego; Armstrong, Paul W.; Avezum, Alvaro; Aylward, Philip E.; Bryce, Alfonso; Chen, Hong; Chen, Ming-Fong; Corbalan, Ramon; Dalby, Anthony J.; Danchin, Nicolas; De Winter, Robbert J.; Denchev, Stefan; Diaz, Rafael; Elisaf, Moses; Flather, Marcus D.; Goudev, Assen R.; Granger, Christopher B.; Grinfeld, Liliana; Hochman, Judith S.; Husted, Steen; Kim, Hyo-Soo; Koenig, Wolfgang; Linhart, Ales; Lonn, Eva; López-Sendón, José; Manolis, Athanasios J.; Mohler III, Emile R.; Nicolau, José C.; Pais, Prem; Parkhomenko, Alexander; Pedersen, Terje R.; Pella, Daniel; Ramos-Corrales, Marco A.; Ruda, Mikhail; Sereg, Mátyás; Siddique, Saulat; Sinnaeve, Peter; Smith, Peter; Sritara, Piyamitr; Swart, Henk P.; Sy, Rody G.; Teramoto, Tamio; Tse, Hung-Fat; Watson, David; Weaver, W. Douglas; Weiss, Robert; Viigimaa, Margus; Vinereanu, Dragos; Zhu, Junren; Cannon, Christopher P.; Wallentin, Lars
Source: The New England Journal of Medicine. Unidade: FM
Subjects: DOENÇAS CARDIOVASCULARES (PREVENÇÃO E CONTROLE), ARTERIOSCLEROSE CORONÁRIA, FOSFOLIPASES A, REAÇÃO EM CADEIA POR POLIMERASE, BIOLOGIA MOLECULAR, ANÁLISE SEQUENCIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WHITE, Harvey D. et al. Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease. The New England Journal of Medicine, v. 370, n. 18, p. 1702-1711, 2014Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa1315878. Acesso em: 03 nov. 2024.
APA
White, H. D., Held, C., Stewart, R., Tarka, E., Brown, R., Davies, R. Y., et al. (2014). Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease. The New England Journal of Medicine, 370( 18), 1702-1711. doi:10.1056/NEJMoa1315878
NLM
White HD, Held C, Stewart R, Tarka E, Brown R, Davies RY, Budaj A, Harrington RA, Steg PG, Ardissino D, Armstrong PW, Avezum A, Aylward PE, Bryce A, Chen H, Chen M-F, Corbalan R, Dalby AJ, Danchin N, De Winter RJ, Denchev S, Diaz R, Elisaf M, Flather MD, Goudev AR, Granger CB, Grinfeld L, Hochman JS, Husted S, Kim H-S, Koenig W, Linhart A, Lonn E, López-Sendón J, Manolis AJ, Mohler III ER, Nicolau JC, Pais P, Parkhomenko A, Pedersen TR, Pella D, Ramos-Corrales MA, Ruda M, Sereg M, Siddique S, Sinnaeve P, Smith P, Sritara P, Swart HP, Sy RG, Teramoto T, Tse H-F, Watson D, Weaver WD, Weiss R, Viigimaa M, Vinereanu D, Zhu J, Cannon CP, Wallentin L. Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease [Internet]. The New England Journal of Medicine. 2014 ; 370( 18): 1702-1711.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1056/NEJMoa1315878
Vancouver
White HD, Held C, Stewart R, Tarka E, Brown R, Davies RY, Budaj A, Harrington RA, Steg PG, Ardissino D, Armstrong PW, Avezum A, Aylward PE, Bryce A, Chen H, Chen M-F, Corbalan R, Dalby AJ, Danchin N, De Winter RJ, Denchev S, Diaz R, Elisaf M, Flather MD, Goudev AR, Granger CB, Grinfeld L, Hochman JS, Husted S, Kim H-S, Koenig W, Linhart A, Lonn E, López-Sendón J, Manolis AJ, Mohler III ER, Nicolau JC, Pais P, Parkhomenko A, Pedersen TR, Pella D, Ramos-Corrales MA, Ruda M, Sereg M, Siddique S, Sinnaeve P, Smith P, Sritara P, Swart HP, Sy RG, Teramoto T, Tse H-F, Watson D, Weaver WD, Weiss R, Viigimaa M, Vinereanu D, Zhu J, Cannon CP, Wallentin L. Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease [Internet]. The New England Journal of Medicine. 2014 ; 370( 18): 1702-1711.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1056/NEJMoa1315878
Artigo de periodico
Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry (2009)
Cacoub, Patrice P.; Abola, Maria Teresa B.; Baumgartner, Iris; Bhatt, Deepak L.; Creager, Mark A.; Liau, Chiau-Suong; Goto, Shinya; Röther, Joachim; Steg, P. Gabriel; Hirsch, Alan T.; Maciel, Léa Maria Zanini; Pazin Filho, Antonio
Source: Atherosclerosis. Unidade: FMRP
Subjects: FATORES DE RISCO, DOENÇAS VASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CACOUB, Patrice P. et al. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Atherosclerosis, v. 204, n. 2, p. e86-e92, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2008.10.023. Acesso em: 03 nov. 2024.
APA
Cacoub, P. P., Abola, M. T. B., Baumgartner, I., Bhatt, D. L., Creager, M. A., Liau, C. -S., et al. (2009). Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Atherosclerosis, 204( 2), e86-e92. doi:10.1016/j.atherosclerosis.2008.10.023
NLM
Cacoub PP, Abola MTB, Baumgartner I, Bhatt DL, Creager MA, Liau C-S, Goto S, Röther J, Steg PG, Hirsch AT, Maciel LMZ, Pazin Filho A. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry [Internet]. Atherosclerosis. 2009 ; 204( 2): e86-e92.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2008.10.023
Vancouver
Cacoub PP, Abola MTB, Baumgartner I, Bhatt DL, Creager MA, Liau C-S, Goto S, Röther J, Steg PG, Hirsch AT, Maciel LMZ, Pazin Filho A. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry [Internet]. Atherosclerosis. 2009 ; 204( 2): e86-e92.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2008.10.023
Artigo de periodico
Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis (2008)
Goto, Shinya; Bhatt, Deepak L.; Röther, Joachim; Alberts, Mark; Hill, Michael D.; Ikeda, Yasuo; Uchiyama, Shinichiro; D'Agostinho, Ralph; Ohman, E. Magnus; Liau, Chiau-Suong; Hirsch, Alan T.; Mas, Jean-Louis; Wilson, Peter W. F.; Corbalán, Ramón; Aichner, Franz; Steg, P. Gabriel; Maciel, Léa Maria Zanini; Pazin Filho, Antonio
Source: American Heart Journal. Unidade: FMRP
Subjects: ARTERIOSCLEROSE, FIBRILAÇÃO VENTRICULAR, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOTO, Shinya et al. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. American Heart Journal, v. 156, n. 5, p. 855-863, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2008.06.029. Acesso em: 03 nov. 2024.
APA
Goto, S., Bhatt, D. L., Röther, J., Alberts, M., Hill, M. D., Ikeda, Y., et al. (2008). Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. American Heart Journal, 156( 5), 855-863. doi:10.1016/j.ahj.2008.06.029
NLM
Goto S, Bhatt DL, Röther J, Alberts M, Hill MD, Ikeda Y, Uchiyama S, D'Agostinho R, Ohman EM, Liau C-S, Hirsch AT, Mas J-L, Wilson PWF, Corbalán R, Aichner F, Steg PG, Maciel LMZ, Pazin Filho A. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis [Internet]. American Heart Journal. 2008 ; 156( 5): 855-863.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.ahj.2008.06.029
Vancouver
Goto S, Bhatt DL, Röther J, Alberts M, Hill MD, Ikeda Y, Uchiyama S, D'Agostinho R, Ohman EM, Liau C-S, Hirsch AT, Mas J-L, Wilson PWF, Corbalán R, Aichner F, Steg PG, Maciel LMZ, Pazin Filho A. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis [Internet]. American Heart Journal. 2008 ; 156( 5): 855-863.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.ahj.2008.06.029
Artigo de periodico
Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry) (2007)
Steinberg, Benjamin; Steg, P. Gabriel; Bhatt, Deepak L.; Fonarow, Gregg C.; Zeymer, Uwe; Cannon, Christopher P.; Maciel, Léa Maria Zanini; Pazin Filho, Antonio
Source: American Journal of Cardiology. Unidade: FMRP
Subjects: CORONARIOPATIA, REVASCULARIZAÇÃO MIOCÁRDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STEINBERG, Benjamin et al. Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry). American Journal of Cardiology, v. 99, n. 9, p. 1212-1215, 2007Tradução . . Acesso em: 03 nov. 2024.
APA
Steinberg, B., Steg, P. G., Bhatt, D. L., Fonarow, G. C., Zeymer, U., Cannon, C. P., et al. (2007). Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry). American Journal of Cardiology, 99( 9), 1212-1215.
NLM
Steinberg B, Steg PG, Bhatt DL, Fonarow GC, Zeymer U, Cannon CP, Maciel LMZ, Pazin Filho A. Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry). American Journal of Cardiology. 2007 ; 99( 9): 1212-1215.[citado 2024 nov. 03 ]
Vancouver
Steinberg B, Steg PG, Bhatt DL, Fonarow GC, Zeymer U, Cannon CP, Maciel LMZ, Pazin Filho A. Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry). American Journal of Cardiology. 2007 ; 99( 9): 1212-1215.[citado 2024 nov. 03 ]

USP Schools

ReP

Filtros

Authors

Date published

Subjects

Source title

Indexado em

Non normalized affiliation

Countries of institutions of collaboration